Balancing Drug Risk and Benefit: Toward Refining the Process of FDA Decisions Affecting Patient Care-Reference-Cited by-同舟云学术

Balancing Drug Risk and Benefit: Toward Refining the Process of FDA Decisions Affecting Patient Care

Published:2008-04 Issue:4 Volume:103 Page:815-819
ISSN:0002-9270
Container-title:The American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterology

Author:

Schiller Lawrence R.,Johnson David A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference27 articles.

1. Postmarketing Surveillance—Lack of Vigilance, Lack of Trust

2. 2. Wolfe S. How independent is the FDA? Available at: http://www.pbs.org/wgbh/pages/frontline/ shows/pres-cription/hazard/independent.html. Accessed November 17, 2007.

3. Paying for Drug Approvals — Who's Using Whom?

4. Gaps, Tensions, and Conflicts in the FDA Approval Process: Implications for Clinical Practice

5. FDA Attempting To Overcome Major Roadblocks in Monitoring Drug Safety

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Let’s talk about sex: Differences in drug therapy in males and females;Advanced Drug Delivery Reviews;2021-08

2. International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function;Pharmacological Reviews;2020-12-22

3. The assessment of patient clinical outcome: A literature discussion;Annals of Tropical Medicine and Public Health;2017

4. Bioprinting 3D microfibrous scaffolds for engineering endothelialized myocardium and heart-on-a-chip;Biomaterials;2016-12

5. Aptamer-Based Microfluidic Electrochemical Biosensor for Monitoring Cell-Secreted Trace Cardiac Biomarkers;Analytical Chemistry;2016-10-04